Marshall Richard Peter - 01 Apr 2024 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
Director
Signature
/s/ Richard Peter Marshall
Issuer symbol
SER
Transactions as of
01 Apr 2024
Net transactions value
$0
Form type
4
Filing time
03 Apr 2024, 20:58:13 UTC
Previous filing
03 Apr 2024
Next filing
10 Nov 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Stock Option (right to buy) Award $0 +40,000 $0.000000 40,000 01 Apr 2024 Common Stock 40,000 $11.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest in three equal installments on April 1, 2025, April 1, 2026 and April 1, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.